Dramatically shorten your drug development timeline + improve chances of success through more informative tissue analysis
Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated pathology world.
From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.
Our unique, proprietary image analysis technology provides thousands of measurements on every cell across an entire slide for data-centric pathology insights on every sample. Flagship’s technology, team, and proven process have provided superior data for hundreds of clinical trials.
Quite simply, we’re changing the drug development paradigm.
Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.
Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.
Download our recent white paper,
“Tissue Image Analysis and Biomarker Assessment Implementation Benefits and ROI”
More accurate and informative tissue data and analytics
Collaboration with our world-renowned scientific team
Increased speed to market for your drug development programs
Enriched clinical diagnostics process for better outcomes